期刊文献+

液-质联用选择离子质谱法测定降糖中成药中添加格列本脲的含量 被引量:1

下载PDF
导出
摘要 目的建立液—质联用(LC-MS)选择离子(S[M])法对平糖宝胶囊中格列本脲的含量进行了测定。方法采用岛津VP-ODS(150 L×2.0,6012554)色谱柱,流动相为0.2%冰乙酸水溶液-乙腈(30∶70),流速为0.2 ml/min;柱温为室温。结果格列本脲线性范围为0.868~8.68 ng,回归方程为Y=392 433X-101 195,r=0.999 7;平均回收率为97.74%。同时测定了4种降糖中成药中格列本脲的含量。结论该法准确度高,重复性好,可作为本制剂的质控方法。
作者 戚瑞 承伟
机构地区 辽宁医学院
出处 《时珍国医国药》 CAS CSCD 北大核心 2010年第8期2072-2074,共3页 Lishizhen Medicine and Materia Medica Research
  • 相关文献

参考文献7

  • 1朱才娟,陶霞,邓渝林,张莉.4种口服降糖药治疗糖尿病的成本-效果分析[J].中国药房,2004,15(1):32-33. 被引量:19
  • 2WILLIAMSJ D,BURINSKYDJ.Mass spectrometric analysisof complex mixtures then and now:the impact of linking liquid chromatography and mass spectrometry[J].International J Mass Spectrometry,2001,212 (1-3):111.
  • 3CHAN S A,CHEN M J,LIU T Y.Determination ofaristolochic acids in medicinal plant and herbal product by liquid chromatography-electrospray-ion trap mass spectrometry[J].Talanta,2003,60 (4):679.
  • 4WONG S K,TSUI S K,KWAN S Y.Analysis of proprietary Chinese medicines for the presence of toxic ingredients by LC/MS/MS[J].J Pharmaceutical and Biomedical Analysis,2002,30 (1):161.
  • 5JONG T T,LE M R,HSIAO S S.Analysis of aristolochic acid in nine sources of Xixin,a traditional Chinese medicine,by liquid chromatography/ atmospheric pressure chemical ionization/ tandem mass spectrometry[J].J Pharmaceutical and Biomedical Analysis,2003,33 (4):831.
  • 6张长久,崔凯荣,徐友宣,朱绍棠.色质联用选择离子检测法在兴奋剂检测中的应用[J].质谱学报,1992,13(3):33-39. 被引量:5
  • 7李晓天,王广基,王素军.LC-MS法测定人血浆中格列苯脲及其在健康志愿者中的药代动力学[J].中国药科大学学报,2004,35(6):532-535. 被引量:5

二级参考文献15

  • 1崔华东,江文德.格列苯脲微粉片剂在4名健康中国男性志愿者中的药动...[J].中国药理学报,1993,14(3):193-197. 被引量:5
  • 2Marchetti P,Giannarelli R,Di-carlo A.et al.Optimization of oral hypoglycaemic therapy[J].Clin Pharmacokinet,1991,21(4):308-317.
  • 3Midha KK,McGilveray IJ,Charette C. GLC determination of plasma levels of intact chlorpropamide of tolbutamide[J].J Pharm Sci,1976,65(4):576-579.
  • 4Emilsson H,Sjoberg M,Svedner M,et al. High-performance liquid chromatograph determination of glibenclamide in human plasma and urine[J].J Chromatogr,1986,383(1):93-102.
  • 5Uihlein M,Sistovaris N. High-performance liquid column and thin-layer chromatographic determination of human serum glibenclamide at therapertic level[J].J Chromatogr,1982,227(1):93-101.
  • 6Rydberg T,Wahlin-Boll E,Melander A.Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatography[J].J Chromatogr,1991,564(1):223-233.
  • 7Niopas I,Daftsios AC.A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies[J].J Pharm Biomed Anal,2002,28(3-4):653-657.
  • 8Khatri J,Qassim S,Abed O.A novel extractionless HPLC fluorescence method for the determination of glyburide in the human plasma:application to a bioequivalence study[J].J Pharm Pharm Sci,2001,4(2):201-206.
  • 9Hsieh S,Selinger K. High-throughput bioanalytical method using automated sample preparation and liquid chromatography-atmospheric pressure ionspray mass spectrometry for quantitative determination of glibebclamide in human serum[J].J Chromatogr B Analyt Technol Biomed Life Sci,2002,772(2):347-356.
  • 10Ramos L,Bakhtiar R,Tse F. Application of liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry in the quantitative analysis of glyburide(glibenclamide)in human plasma[J].Rapid Commun Mass Spectrum,1999,13(24):2439-2443.

共引文献26

同被引文献23

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部